Access Now: AORN COVID-19 Clinical Support

Archive January 2019 XX, No. 1

5 Innovations in Infection Control

The latest products and practices to help you bust those bugs.

Dan O

Dan O'Connor, Editor-in-Chief


From biological indicators to sterilization containers, here’s a breakdown of the latest weapons you can add to your bug-busting arsenal as part of a bundled approach for reducing the risk of surgical site infections (SSIs).

30-MINUTE BI The Sterrad Velocity biological indicator (BI) system from Advanced Sterilization Products.

1 Rapid readout technology. There is now a 30-minute biological indicator (BI) for all Sterrad (hydrogen peroxide gas plasma) sterilizers. Until now, the only approved BI couldn’t be read for 24 hours. However, with the Sterrad Velocity, it is now feasible to hold the sterilized load until the BI is read, says Luci Perri, RN, BSN, MSN, MPH, CIC, FAPIC, founder and president of Infection Control Results, based in North Carolina. The BI is compatible with all features of the Sterrad sterilizer, including a touchscreen reader with results that can be sent directly to a computer, she adds.

NASAL ANTISEPTICS Nasal decolonization has been used for several high-risk procedures such as cardiothoracic and orthopedic surgeries.

2 Nasal decolonization. The practice of nasal decolonization using a topical antibiotic in specific patient populations has been largely replaced with non-antibiotic nasal antiseptics that to date have not shown any antimicrobial resistance, says Phenelle Segal, RN, CIC, FAPIC, president of Infection Control Consulting Services.

“They’re fast acting, have a persistence that lasts for several hours before having to reapply, and the alcohol-based product has a pleasant citrus aroma,” adds Ms. Segal.

Nasal bacteria are a primary component in the spread of infection. Nasal antiseptics have obviated the need to apply the antibiotic product for 5 to 10 days, which often results in non-compliance and antimicrobial resistance. In addition, nasal antiseptic decolonization is replacing the need to “screen and isolate” patients colonized with multi-drug resistant Staphylococcus aureus such as MRSA, which saves money, time and other resources.

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

5 Tips for More Efficient Sterile Processing

How one hospital turned its SPD into a shining example of excellence.

Hold Anesthesia Providers

Accountable in the Battle Against SSIs Q&A with Silvia Munoz-Price, MD, PhD, infectious disease specialist and proponent of proper infection control practices.

Prewarming Works Wonders

Early interventions to maintain normothermia reduce infection risks and increase patient satisfaction.